Edition:
United States

Alere Inc (ALR)

ALR on New York Consolidated

39.07USD
28 Mar 2017
Change (% chg)

$0.04 (+0.10%)
Prev Close
$39.03
Open
$39.01
Day's High
$39.11
Day's Low
$38.70
Volume
95,360
Avg. Vol
623,940
52-wk High
$51.00
52-wk Low
$31.47

Select another date:

Tue, Mar 21 2017

BRIEF-Alere receives NYSE notice regarding late form 10-K filing

* Alere Inc receives NYSE notice regarding late form 10-K filing Source text for Eikon: Further company coverage:

BRIEF-Alere says will be unable to file 2016 form 10-K within extension period

* Alere says will be unable to file 2016 form 10-K within extension period as it is continuing to review certain aspects of revenue recognition at Korean and Japanese locations

Alere unit loses bid to block Medicare enrollment revocation

A subsidiary of diagnostic testing company Alere Inc on Thursday lost an effort in court to block the U.S. Centers for Medicare and Medicaid Services from revoking its Medicare enrollment for submitting claims for 211 patients who were already dead.

BRIEF-Alere provides update on Arriva Medical

* Disagree with court's ruling on Arriva's motion for interim relief

BRIEF-Alere receives FDA CLIA waiver for Alere i RSV rapid molecular test

* Alere receives FDA CLIA waiver for Alere™ i RSV rapid molecular test

Diagnostic company Alere to delay filing annual report

Alere Inc said it would delay filing its 2016 annual report, in the latest blow to the diagnostic company engaged in a legal battle with Abbott Laboratories over their deal.

UPDATE 2-Diagnostic company Alere to delay filing annual report

March 1 Alere Inc said it would delay filing its 2016 annual report, in the latest blow to the diagnostic company engaged in a legal battle with Abbott Laboratories over their deal.

Diagnostic company Alere says to delay filing annual report

March 1 Diagnostic company Alere Inc said on Wednesday it would delay filing its 2016 annual report as it was reviewing the revenue recognition practices at its South Korean and Japanese units.

BRIEF-Alere Inc files for non-timely 10-K

* Alere - unable to file 10-K within prescribed time period because co is reviewing certain aspects of revenue recognition at Korean, Japanese locations

EU mergers and takeovers (Jan 25)

BRUSSELS, Jan 25 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

Select another date:

More From Around the Web